|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-3-6
|
|
pubmed:abstractText |
Mitoxantrone (Mx) is used as a second-line treatment in multiple sclerosis. Since 1998, eight cases of acute leukemia (AL) have been described. We report two new cases of myeloid AL that occurred during treatment with Mx.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0035-3787
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
162
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
195-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
[Acute leukaemia in two multiple sclerosis patients treated with mitoxantrone].
|
|
pubmed:affiliation |
Service de Neurologie, Hôpital Jean Minjoz, Besançon. nolletsylvain@yahoo.fr
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
